Editorial
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Editorial
- Editorial
- Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind
- Beom Kyung Kim
- Received June 30, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0499 [Accepted]
-
View: 119 Download: 3
- Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is tenofovir better than entecavir?
- Yewan Park, Dong Hyun Sinn
- Received July 4, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0519 [Accepted]
-
View: 136 Download: 21
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
